HUE031823T2 - A method for producing reduced dissolved human albumin at dissolved oxygen level - Google Patents

A method for producing reduced dissolved human albumin at dissolved oxygen level Download PDF

Info

Publication number
HUE031823T2
HUE031823T2 HUE15382164A HUE15382164A HUE031823T2 HU E031823 T2 HUE031823 T2 HU E031823T2 HU E15382164 A HUE15382164 A HU E15382164A HU E15382164 A HUE15382164 A HU E15382164A HU E031823 T2 HUE031823 T2 HU E031823T2
Authority
HU
Hungary
Prior art keywords
albumin
solution
ahol ahol
stage
oxygen
Prior art date
Application number
HUE15382164A
Other languages
English (en)
Hungarian (hu)
Inventor
Nieto Juan Ignacio Jorquera
Fernandez Ana Maria Ortiz
Rierola Montserrat Costa
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52003454&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE031823(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of HUE031823T2 publication Critical patent/HUE031823T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HUE15382164A 2014-05-29 2015-04-01 A method for producing reduced dissolved human albumin at dissolved oxygen level HUE031823T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201430824A ES2524516B1 (es) 2014-05-29 2014-05-29 Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido

Publications (1)

Publication Number Publication Date
HUE031823T2 true HUE031823T2 (en) 2017-08-28

Family

ID=52003454

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15382164A HUE031823T2 (en) 2014-05-29 2015-04-01 A method for producing reduced dissolved human albumin at dissolved oxygen level

Country Status (22)

Country Link
US (1) US10350274B2 (OSRAM)
EP (1) EP2952203B9 (OSRAM)
JP (3) JP2015224251A (OSRAM)
KR (1) KR101960729B1 (OSRAM)
CN (1) CN105315362B (OSRAM)
AR (1) AR100618A1 (OSRAM)
AU (1) AU2015202413B2 (OSRAM)
BR (1) BR102015012091A8 (OSRAM)
CA (1) CA2890642C (OSRAM)
CL (1) CL2015001446A1 (OSRAM)
ES (2) ES2524516B1 (OSRAM)
HU (1) HUE031823T2 (OSRAM)
IL (1) IL238898B (OSRAM)
MX (1) MX362869B (OSRAM)
MY (1) MY171771A (OSRAM)
NZ (1) NZ708537A (OSRAM)
PL (1) PL2952203T3 (OSRAM)
PT (1) PT2952203T (OSRAM)
RU (1) RU2657578C2 (OSRAM)
SG (1) SG10201504137PA (OSRAM)
TW (1) TWI607018B (OSRAM)
ZA (1) ZA201503539B (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2524516B1 (es) * 2014-05-29 2015-03-31 Grifols Worldwide Operations Limited Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido
ES2975517T3 (es) 2016-04-28 2024-07-08 Alkahest Inc Fracciones de plasma como terapia para el cáncer de timo
SG11201901273TA (en) 2016-08-18 2019-03-28 Alkahest Inc Blood plasma fractions as a treatment for aging-associated cognitive disorders
CN117899111A (zh) 2017-04-26 2024-04-19 万能溶剂有限公司 用血浆和血浆制品治疗认知障碍和运动障碍的给药方案
KR20210024196A (ko) 2018-07-20 2021-03-04 알카헤스트 인코포레이티드 혈장 및 혈장 산물로 인지 및 운동 장애를 치료하기 위한 투여 요법
UA128648C2 (uk) 2018-10-26 2024-09-18 Алкахест, Інк. Застосування плазми крові та фракцій плазми для пом'якшення болю, поліпшення загоювання ран та післяопераційного відновлення
CN109627322A (zh) * 2019-01-07 2019-04-16 中国科学院过程工程研究所 一种从Cohn组分Ⅴ上清中分离纯化人血清白蛋白的方法
CA3151943A1 (en) 2019-11-04 2021-05-14 Viktoria Kheifets Blood plasma fractions for use in muscle regeneration
EP4061384A4 (en) 2019-11-20 2023-11-01 Alkahest, Inc. BLOOD PLASMA FRACTIONS FOR USE IN LIVER REGENERATION
JP2026511640A (ja) 2023-03-29 2026-04-14 グリフォルス・ワールドワイド・オペレーションズ・リミテッド ＦｃεＲＩβ自己抗体のレベルが低減された血漿製剤の組成物および調製方法
CN118166053B (zh) * 2024-03-15 2025-02-07 通化安睿特生物制药股份有限公司 一种制备低o-糖基化水平的重组人白蛋白的方法
WO2025230830A1 (en) 2024-04-29 2025-11-06 Alkahest, Inc. Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4094965A (en) * 1977-04-01 1978-06-13 New England Nuclear Corporation Diagnostic agents containing albumin and method for making same
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
SE9402119D0 (sv) * 1994-06-16 1994-06-16 Pharmacia Ab Solution
US5766582A (en) * 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
JP4254117B2 (ja) * 2001-03-27 2009-04-15 ニプロ株式会社 アルブミン溶液収容プラスチック容器
DE60234142D1 (de) * 2001-03-27 2009-12-10 Nipro Corp Albuminlösung enthaltender Kunststoffbehälter
JP4225416B2 (ja) * 2001-06-29 2009-02-18 旭化成ファーマ株式会社 タンパク質製剤の安定性を改善する方法
US7252799B2 (en) * 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
ATE342904T1 (de) * 2003-08-28 2006-11-15 Nipro Corp Künstlicher sauerstoffträger und herstellungsverfahren dafür
RS52459B (sr) * 2006-02-07 2013-02-28 Shire Human Genetic Therapies Inc. Stabilizovane kompozicije glukocerebrozidaze
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
JP5990880B2 (ja) * 2011-08-31 2016-09-14 東レ株式会社 有用タンパク質組成物およびその製造方法
CN102816230B (zh) * 2012-08-27 2014-02-12 同路生物制药股份有限公司 人血白蛋白的制备方法
ES2524516B1 (es) * 2014-05-29 2015-03-31 Grifols Worldwide Operations Limited Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido

Also Published As

Publication number Publication date
RU2657578C2 (ru) 2018-06-14
PT2952203T (pt) 2016-11-23
CA2890642A1 (en) 2015-11-29
JP2018115210A (ja) 2018-07-26
CN105315362A (zh) 2016-02-10
MX362869B (es) 2019-02-20
KR101960729B1 (ko) 2019-03-21
US20170000855A9 (en) 2017-01-05
ZA201503539B (en) 2017-01-25
NZ708537A (en) 2017-06-30
EP2952203B1 (en) 2016-10-26
ES2524516B1 (es) 2015-03-31
BR102015012091A8 (pt) 2021-03-16
KR20160024348A (ko) 2016-03-04
CN105315362B (zh) 2019-10-25
BR102015012091A2 (pt) 2016-01-05
JP2020111614A (ja) 2020-07-27
AU2015202413B2 (en) 2017-08-31
CL2015001446A1 (es) 2016-05-13
TWI607018B (zh) 2017-12-01
CA2890642C (en) 2019-02-12
MX2015006407A (es) 2015-11-30
AR100618A1 (es) 2016-10-19
MY171771A (en) 2019-10-29
US10350274B2 (en) 2019-07-16
IL238898B (en) 2018-01-31
EP2952203A1 (en) 2015-12-09
PL2952203T3 (pl) 2017-02-28
US20150343025A1 (en) 2015-12-03
RU2015118453A (ru) 2016-12-10
EP2952203B9 (en) 2018-03-14
JP2015224251A (ja) 2015-12-14
AU2015202413A1 (en) 2015-12-17
ES2601137T3 (es) 2017-02-14
ES2524516A1 (es) 2014-12-09
SG10201504137PA (en) 2015-12-30
TW201544510A (zh) 2015-12-01

Similar Documents

Publication Publication Date Title
EP2952203B9 (en) Method for the preparation of human albumin with reduced level of dissolved oxygen
Matejtschuk et al. Production of human albumin solution: a continually developing colloid
Gleich et al. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils.
DE69202049T2 (de) Verfahren zur reinigung von intaktem und korrekt gefaltetem igf-i.
DK2937359T3 (en) Chromatographic method for isolating and purifying high purity human serum albumin
EA025663B1 (ru) Композиции этанерцепта, стабилизированные ионами металлов
JP2014098029A (ja) 安定な液体インターフェロン処方物
Murphy et al. Erythrocyte microtubule assembly in vitro. Determination of the effects of erythrocyte tau, tubulin isoforms, and tubulin oligomers on erythrocyte tubulin assembly, and comparison with brain microtubule assembly.
JP6611291B2 (ja) 新規な抗菌ペプチド及びその用途
JPH0733800A (ja) 精製単量体健康人血清アルブミン（ヒト）
Scudder STUDIES IN BLOOD PRESERVATION*: THE STABILITY OF PLASMA PROTEINS
Idar et al. Purification of IgY Anti-SARS-CoV-2-Chicken Nucleocapsid and elimination of its low-temperature storage-induced aggregates
CN1749274B (zh) 一种新的重组人干扰素α2b的分离纯化方法
DE60304603T2 (de) Plasma-albumin fraktion mit vermindertem prekallikrein
Arvinte et al. The formulation of biological molecules
DE60304040T2 (de) Methode zur identifizierung und eliminierung von t-zell epitopen
US20240228566A1 (en) Compositions and methods for vascular protection after myocardial ischemia
RU2391354C1 (ru) Комплекс биологически активного рекомбинантного белка с полисиаловой кислотой
Vahidzadeh et al. Studies on the interaction of colchicine and human serum albumin by the measurement of zeta-potential
Ebrahim-Damavandi et al. Reducing allergenicity of bovine beta lactoglobulin throughout Cu complexes
CN101015684B (zh) 一种重组人红细胞生成素溶液制剂
Surovikina The half-life of the different serum protein fractions in the circulating blood
Combridge et al. Plasma protein fraction: the disappearance of kinin from the solution on storage
Edeni et al. Biochemical nutritional parameters and anthropometry measurements in Nigerian pulmonary tuberculos patients before and during chemotherapy
Mohamed et al. Systematic studies to correlate microcalorimetry with stability studies on liquid formulations of various protein drugs